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                  To my family! 
  
 
ABSTRACT 
Congenital heart block (CHB) may develop in the fetus during pregnancy in Ro/SSA positive 
women. It is a rare but life-threatening disease and the most serious manifestation of neonatal 
lupus erythematosus (NLE). The frequency of CHB in Ro/SSA autoantibody positive 
pregnancy is 1-2%, with a recurrence rate of 12-17%. Development of CHB may be monitored 
by Doppler/echocardiography examinations during gestational week (GW) 18-24 when early 
signs of CHB are most likely to occur. The surveillance enables early treatment and may 
reverse the inflammatory process in the fetal heart. Although this has been known for a decade, 
little is known about how Ro/SSA autoantibody positive mothers experience their pregnancy 
when being at risk for having a child with CHB or actually give birth to a child with CHB. 
Furthermore little is known about the neurodevelopment in the children born with CHB. The 
aim of this thesis was therefore to investigate Ro/SSA autoantibody positive women’s 
experience of pregnancy and the postnatal period as well as neurodevelopment in children with 
CHB. 
 
A main finding of the studies is that the awareness and knowledge of Ro/SSA 
autoantibodies and associated risk for CHB is low both among health care personnel as well as 
women/families involved. Further, there is a lack of adequate and sufficient information 
available. The majority of the participants in the study received the information of their own 
autoantibody positivity as well as the connection to risk for CHB when they were already 
pregnant. Most women stated that they wanted the information as soon as the autoantibody 
positivity was known, if possible before pregnancy in order to prepare and adjust to the 
situation. The majority of the women also stated that the information would not have influence 
their decision of becoming pregnant. A majority of the women giving birth to children with 
CHB stated that they did not receive enough information. Our studies showed that the 
informant was an important factor predicting how the women experienced the information, 
where information communicated by someone with specialization in pediatric cardiology was 
significantly more often experienced as sufficient and understood by the women. The serial 
Doppler/echocardiography examinations did not induce anxiety, but rather coming to a highly 
specialized center and getting the possibility to interact and to get information and support from 
the staff was experienced as a benefit by the women. Women giving birth to a child with CHB 
often wished for more support. When investigating neurodevelopment, our data indicate that in 
addition to well established factors such as male sex and being born preterm, both maternal 
systemic lupus erythematosus (SLE) and CHB may influence neurodevelopment. 
 
In conclusion, the result from this study highlights the vulnerable situation that 
women and their families experience when there is a risk for the child to develop CHB. We 
conclude that it is important to develop structured programmes for the surveillance of 
pregnancy in women who are SSA/Ro52 positive and to refer these women to specialized 
centers where the experience to manage the situation and with the possibility of maintaining 
updated information, surveillance and treatment is available. Such programme should also 
include guidelines for the involved personnel in the chain of care and make relevant 
information accessible for the women/families. Offering professional psychological support to 
the women and families should also be considered. In particular, for the women that gave birth 
to a child with CHB, the surveillance programme should range into the post partum period, and 
also involve the primary child care center to bridge the gap between different care givers. In 
addition, follow up of neurodevelopment should be considered for children with CHB, 
especially if the mother is diagnosed with SLE. An early diagnosis is one way to help these 
children overcome their difficulties during childhood and school years and make sure that they 
obtain the support needed. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Två sanningar närmar sig varann. 
En kommer inifrån, 
en kommer utifrån 
och där de möts har man en chans att få se sig själv. 
              Tomas Tranströmmer  
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1 INTRODUCTION 
1.1 PREGNANCY 
1.1.1 Transition to motherhood and preparation of parenthood 
Pregnancy is a time of transition in a woman’s life, characterized by psychological 
processes and biological changes. Transitions are times of change, vulnerability, and 
transformation (Meleis et al., 2000). The transition to parenthood is a major life change that 
requires ability to adapt to a previously unknown situation and self-redefinement is needed to 
take on the maternal role (Mercer, 2004). A characteristic of the parenthood transition is that it 
takes place during an undefined period of time, with new life goals including ensuring the 
infant´s survival and letting the infant become the primary focus of attention (Stern, 1998).   
The mental and psychological preparation for parenthood may start a long time 
before the pregnancy, but increases during pregnancy (Condon, 1997; Hjelmstedt et al., 2006; 
Leifer, 1977). Fantasies about the child and what life will be like as a family, as well as 
increased emotional sense have been suggested to contribute to the preparation for parenthood 
(Stern and Bruschweiler-Stern, 1998). During pregnancy, particular events such as feeling the 
fetal movements or seeing the fetus during an ultrasound exam seem to improve prenatal 
attachment (Ekelin et al., 2004; Kowalcek et al., 2003b). The engagement in the fetus during 
pregnancy has also been suggested to predict engagement in the infant after birth (Figueiredo 
and Costa, 2009; Siddiqui and Hägglöf, 2000). The early mother-infant relationship is of critical 
importance, because it forms the basis for the child’s future social and cognitive development. 
Maternal behaviors such as sensitivity, acceptance and co-operation have been associated with 
the establishment and maintenance of a positive relationship with her infant (Ainsworth, 1979). 
 
1.1.2 Ultrasound during pregnancy 
Fetal diagnostics is the generic term for the examinations, screening and diagnostic 
examinations that can be performed during pregnancy. By using different techniques it is 
possible to detect and exclude certain diseases and injuries but it is never a guarantee for a 
healthy child (Georgsson Ohman et al., 2004).  The ultrasound examination has become an 
almost universal part of antenatal care in developed countries (Garcia et al., 2002). Ultrasound 
examinations during pregnancy were introduced in Sweden in 1973. This non-invasive 
technique is now used for fetal diagnostics and offered as a routine procedure accepted in 97% 
of all pregnancies (Marsal and Malcus, 2008) predominantly in the second trimester (gestational 
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week 16-20)  It is organized within the National Health Care System, and the primary medical 
indication to perform the examination is confirmation of gestational age, localization of the 
placenta and the detection of a multiple pregnancy (SBU, 2006). 
The reasons for the women and their partners for undertaking the examination can be 
different and have been explored in several studies (Gudex et al., 2006; Lalor and Devane, 
2007; Larsen et al., 2000). The reasons for an ultrasound examination are to know whether the 
child has malformations or if a multiple pregnancy exists (Ekelin et al., 2004; Gudex et al., 
2006; Lalor and Devane, 2007; Larsen et al., 2000) Other  reasons can be the need for 
reassurance, confirmation of a new life and looking at their child as a way of connecting with 
their child and “becoming a family” for the first time  and parents are therefore often  not 
prepared for anomalies if detected (Crang-Svalenius et al., 1996; Eurenius et al., 1997; Garcia et 
al., 2002; Kowalcek et al., 2003a; Molander et al., 2010).. As the ultrasound technique has 
developed, it has become possible to detect a variety of malformations, including congenital 
heart defects such as congenital heart block (CHB) during the second trimester (Paladini et al., 
1993). One technique to investigate the blood flow and circulation in for example the placenta 
and the umbilical cord or to look at the conduction in the fetal heart is the Doppler/ ultrasound 
examination. 
    
1.2 HIGH- RISK PREGNANCY 
The definition of a high risk pregnancy is “an increased risk of mortality and 
morbidity due to fetal, maternal or placental defects” (O'Brien et al., 2010). The high risk 
definition is used to indicate that physiological, psychological, individual and/or environmental 
factors exist during pregnancy that can be a risk for the maternal and/or fetal health. In general 
women with a high risk pregnancy will experience more anxiety than women with a normal 
pregnancy (Gupton et al., 2001). Just the fact to be labeled as “high-risk” may cause fragility 
and physical vulnerability (McCain and Deatrick, 1994). Women being at risk during pregnancy 
have stated that they sometimes put their pregnancy “on hold” when being in a risk period 
(Ahman et al., 2010; Carolan and Hodnett, 2009). To struggle to come to terms with a situation 
when the fetal health is at risk, has been described as “trying not to be pregnant” as the women 
await the findings of genetic testing (Georgsson Ohman et al., 2004). In the study by Carolan 
and colleague 2009, participants expressed that they hold back their feelings of anticipation and 
excitement, and that they  distanced themselves from the unborn baby (Carolan and Hodnett, 
2009). This has also been described as a state of suspended investment in pregnancy related to 
 13 
 
concerns around fetal abnormality (Carolan, 2005; Georgsson Ohman et al., 2004). It has been 
suggested that a poor prenatal engagement in the fetus is a predictor for poor engagement in the 
infant postpartum (Siddiqui and Hägglöf, 2000).      
High-risk pregnancies require more medical monitoring which can be perceived as a 
less humanized care from the woman’s perspective, where technical equipment and advanced 
medical tests receive a central role. There is also a special situation from the clinicians’ 
perspective when caring for a high-risk pregnant woman. In a study from 2010, Pozzo et al 
found that 76% of the involved staff at a high-risk pregnancy clinic had difficulty in relating to 
and communicating with the patients (Pozzo et al., 2010). 
 
1.3 PREGNANCY COMPLICATIONS IN SYSTEMIC RHEUMATIC 
DISORDERS 
1.3.1 The immune system during pregnancy 
A pregnancy involves physiological and hormonal changes for the woman. The 
maternal immune system is regulated to accept and not reject the fetus, a process in which the 
placenta is central. Dysfunction of the immune balance may result in e.g. preeclampsia 
(Matthiesen et al., 2005). Further, immune related rheumatic disease may deteriorate or even 
develop during pregnancy. For women who suffer from systemic rheumatic disorders the 
condition can influence reproduction and there is an increased risk of adverse outcome such as 
repeated fetal loss, intrauterine growth restriction and preterm birth (Märker-Hermann and 
Fischer-Betz, 2010; Tincani et al., 2006). 
 
1.3.2 Systemic lupus erythematosus and Sjögren’s syndrome 
Systemic Lupus Erythematosus (SLE) and primary Sjögren’s Syndrome (pSS) are 
both autoimmune inflammatory rheumatic diseases characterized by B cell hyperactivity and 
presence of autoantibodies. While pSS commonly affects exocrine glands with lymphocytic 
infiltrates and progressive tissue destruction (Jonsson et al., 2000), SLE is a more severe disease 
involving many organs and is characterized by the deposition of immune complexes, especially 
in the kidneys, joints, skin and blood vessels leading to glomerulonephritis, arthritis, skin rash 
and vasculities (Klippel, 1997). 
Today, women with inflammatory rheumatic diseases can be encouraged to become 
pregnant, when there is a stable and quiescent phase of the disease. When the pregnant woman 
have a rheumatic diagnosis it is important to carefully and accurately penetrate the anamnesis in 
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order to understand disease activity and define parameters that may influence the pregnancy.  
Sjögren’s syndrome may affect women of all ages but is most frequent between 40-50 years of 
age. However, early-onset of primary Sjögren’s Syndrome is usually associated with more 
systemic disease complications and high concentrations of autoantibodies (Hussein et al., 2011; 
Ramos-Casals et al., 2008). The study by Hussein and colleagues from 2011 showed that 
maternal age was higher in pSS patients, birth weight in pSS offspring lower and delivery by 
Caesarean section or vacuum extraction more frequent than in the general population. The 
increased risk for surgical delivery is mainly due to an increased risk of fetal growth restriction 
in the pSS pregnancies, resulting in increased risk of severe fetal outcome.  
  The onset of SLE often occurs when a woman is in her fertile years, and 
pregnancy and its outcome is a major concern of most SLE patients. It is important that a 
woman with SLE and her partner who wants to become parents discuss their wish and various 
aspects of pregnancy with a rheumatologist. Whether there is an increased risk of SLE flares 
during pregnancy remains controversial. As a general rule, the longer a patient has been in 
remission at the time of conception, the higher is the chance that she can complete the 
pregnancy without experiencing a disease exacerbation (Mok and Wong, 2001).  The risk of a 
miscarriage during an SLE-pregnancy is 20-40% and the risk for premature birth (<37 GW) is 
around 40% (Skomsvoll et al., 1998). One of the reasons for the increased risk is the presence of 
anti-phospholipids antibodies (APL), which has been found in SLE patients. APL have been 
shown to cause intra-placental thrombosis, leading to placental insufficiency and miscarriages, 
usually in the second and third trimester (Ginsberg et al., 1992; Tincani et al., 1998). 
Differentiation between pre-eclampsia and flare of SLE during pregnancy can be 
difficult. Both conditions can cause hypertension, protein urea, oedema and deteriorating renal 
function, and all symptoms may be present in the same patient. A distinction between the two 
conditions is however important because the management is different (Buyon and Szer, 1986; 
Petri, 1998). 
SLE and pSS are partly overlapping diseases, and patients with both diagnoses may 
be positive for SSA/SSB autoantibodies. The risk of fetal loss in p SS was reported as similar to 
that in women with SLE (Julkunen et al., 1995). Larger studies are however needed to 
understand the underlying causes and mechanisms behind outcome factors in pregnancy in pSS 
patients. Today, it is likely that most women with rheumatic diagnoses will complete their 
pregnancy without serious complications for the mother or child thanks to the combined efforts 
from different specialist care-givers. It is important that involved health care professionals work 
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together as a team and at the same time interdependently, since no discipline of the team has the 
complete skill or knowledge required to care for the complex maternal-fetal relation (Handley 
and Collins, 2008; Saar et al., 2006). 
 
1.4 AUTOIMMUNITY TO Ro/SSA AND LA/SSB PROTEINS 
 Recent data show that subspecifities of Ro52 autoantibodies induce congenital heart 
block (CHB) (Ambrosi and Wahren-Herlenius, 2012; Salomonsson et al., 2005). Based on this 
observation immune-serologic assays have been developed that allow identification of high risk 
pregnancies with respect to CHB (Strandberg et al., 2010). These pregnancies can then be 
monitored by Doppler/echocardiography surveillance during susceptibility weeks 18-24. Below 
follows a short description of the Ro and La antigens, the detailed understanding of which 
enabled the identification of the pathogenic Ro/SSA autoantibodies.    
Patients with SLE and SS often have autoantibodies against Ro/SSA and La/SSB.  
The Ro/SSA antigen refers to two non-homologues proteins, the 52 kilo Dalton (kD) protein 
Ro52 and the 60 kD protein Ro60. Ro52 contains a RING and a B-box, a coiled-coil domain 
and is expressed mostly in immune-related organs and cells. Ro52 is expressed in immune cells 
and is mainly localized in the cell cytoplasm but can translocate into the nucleus upon 
inflammatory stimuli. The biological function of Ro52 is as a RING-dependent E3 ligase 
involved in ubiquitination and regulation of immune responses (Espinosa et al., 2009; Espinosa 
et al., 2006).  
The RING, B-box and coiled coil motif places Ro52 in the family of tripartie motif 
proteins, TRIMs (Reymond et al., 2001). Many of the TRIM proteins Ro52 has been shown to 
have E3 ligase activity and acts in the ubiquitination process (Espinosa et al., 2006). The 
ubiqunation is a mechanism of post-translational modification of proteins that allows cells to 
control biological processes such as protein degradation, trafficking and activation (Hershko et 
al., 1983). Many of the proteins in the TRIM family play an important role in innate immunity 
and antiviral responses (Nisole et al., 2005), but also in the regulation of immune responses by 
targeting molecules involved in the cell proliferation, survival and death (McNab et al., 2011). 
The term Ro52 is commonly used when discussing autoantibodies in the clinical situation, but 
as a TRIM protein Ro52 is also called TRIM21, which is the formal name of the Ro52 gene 
(Reymond et al., 2001). 
 When the maternal autoantibodies to Ro52, Ro60 or La are passively transported 
cross the placenta during pregnancy they can injure the previously normal fetal heart 
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(Franceschini and Cavazzana, 2005; Wahren et al., 1996). Autoantibodies targeting the 52-kDa 
component of the Ro antigen are the antibodies most closely associated with CHB. In vitro 
experiments and animal models of CHB also point to a major role for anti-Ro52 antibodies 
targeting amino acids 200-239 in CHB pathogenesis, and suggest that these might directly bind 
cardiomyocytes and affect calcium regulation in the fetal heart, leading to disturbances in signal 
conduction or electro genesis or both (Ambrosi and Wahren-Herlenius, 2012). As reviewed by 
Wolin et al (Wolin and Reinisch, 2006), Ro60 is a ubiquitously expressed RNA-binding protein 
shaped like a doughnut with an inner hole. In the cell, Ro60 binds a family of small cytoplasmic 
RNAs, hYRNA 1-5. While the function of Ro60 was unknown for many years, experiments 
have now demonstrated that this protein binds misfolded non-coding RNAs in vertebrae cells 
and likely functions in a pathway by which defective RNAs are recognized and targeted for 
degradation (Chen et al., 2003; Labbé et al., 1999; O'Brien and Wolin, 1994). It has also been 
shown that the Ro60 protein is important for cell survival after ultraviolet irradiation (Chen et 
al., 2000; Chen et al., 2003).  The La protein can also associate with the hYRNAs and has been 
suggested to have a function in transcription termination and may also be involved in virus 
replication (Wolin and Cedervall, 2002). Notably, while antibodies towards Ro52 seem to be 
the major link to CHB, Ro60 and La autoantibodies may amplify the pathogenic cascade and 
bind intracellular proteins exposed on the cell surface during apoptosis(Ambrosi and Wahren-
Herlenius, 2012).   
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Figure 1. Relation of CHB to maternal diagnosis and autoantibody positivity. The mothers of 
children with CHB may be diagnosed with SLE or Sjögren's syndrome, but may also be carriers 
of Ro/SSA autoantibodies without any clinical manifestations of rheumatic disease.  
 
1.5 NEONATAL LUPUS ERYTHEMATOSUS (NLE) 
Neonatal lupus erythematosus (NLE) occurs in children born to mothers with 
antibodies to SSA/Ro and/or SSB/La. The mothers are often diagnosed with SLE or Sjögren’s 
syndrome. However, many cases also occur in infants of mothers who have the autoantibodies, 
but who do not have symptoms of lupus or other autoimmune disease at the time of pregnancy 
or delivery. Neonatal lupus includes several clinical manifestations as described below. 
 
1.5.1 Cutaneous lesions 
One of the most common manifestations of NLE is cutaneous lesions (Buyon and 
Clancy, 2003). NLE has been reported to occur in 15-25% of infants exposed to SSA/Ro 
antibodies in utero, but the true incidence is unknown since it is probably underreported and 
mistaken for other neonatal rashes (Lee and Weston, 1997). The lesions are often seen in the 
face but can also be found on the trunk, diaper area or extremities (Weston et al., 1999).  The 
skin lesions are photosensitive but can occur even if not sun exposed (Friedman et al., 2002; 
Lee, 2010; Neiman et al., 2000).    
 
Ro/SSA autoantibodies 
 
SLE 
CHB 
 Sjögren’s  
Syndrome 
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Figure 2. Photograph of a newborn infant with cutaneous NLE lesions. From: J Invest     
Dermatol Symp Proc 2011. 
 
1.5.2 Liver and hematological complications 
Liver involvement connected to NLE is often asymptomatic and seen in elevated 
liver function tests, such as alanine aminotransferase and or aspartate aminotransferase 
(Silverman and Jaeggi, 2010). Hematological disorders, such as anemia and thrombocytopenia, 
also occur, but less frequently (Selander et al., 1998; Wolach et al., 1993). Mostly the infants do 
not display any clinical symptoms but in a study by Cimaz and colleagues where 120 infants 
who had been exposed to anti-SSA/Ro antibodies were followed, 26% had at least one liver test 
abnormality (Cimaz et al., 2003). Symptoms of liver dysfunction or a hematological disorder 
are transient and will resolve as maternal autoantibodies are cleared from the child’s circulation 
at approximately 6-8 months of age (Friedman 2002, Lee 2009). Breastfeeding, which 
theoretically prolongs the exposure of the infant to maternal autoantibodies, does not appear to 
influence the development of NLE skin lesions (Askanase 2002, Klauninger et al 2009). If a 
child to a mother with anti-SSA/Ro antibodies shows no signs of NLE, screening for 
hematologic, hepatic or neurologic changes is not recommended. If, however, the infant 
becomes ill, the risk of NLE should be taken in consideration (Wahren Herlenius et al., 2012). 
 
1.5.3 Other complications including neurological involvement 
Beside the cutaneous, liver and hematological involvement, NLE has also been 
suggested to involve neurologic manifestations. Nakayama-Furukawa and colleagues described 
two cases of hydrocephalus connected to NLE (Nakayama-Furukawa et al., 1994). A study that 
prospectively examined 87 infants born to mothers with Ro/SSA autoantibodies 8% of the 
children had hydrocephalus, concluding that hydrocephalus should be considered as a new 
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manifestation of NLE (Boros et al., 2007).  When combining CT scan and ultrasounds on 
infants with coetaneous NLE mild abnormalities were found. The most frequent findings were 
non-specific white matter changes and calcification of the basal ganglia. Rare cases of 
macrocephaly, vasculopathy and transient myasthenia gravis are also found (Cabanas et al., 
1996; Kaye et al., 1987). Another rare condition related to CHB is Chonrodysplasia punctata,   
characterized by radiographic stippling of the epiphyses and/or spine. In general, it resolves 
without treatment during childhood, within the first year. Through the years more than 15 cases 
of Chonrodysplasia punctata have been associated with maternal autoantibodies and it is 
therefore likely that it is a skeletal manifestation of NLE (Austin-Ward et al., 1998; Chitayat et 
al., 2008; Elcioglu and Hall, 1998; Honda et al., 2008; Kelly et al., 1999; Kozlowski et al., 
2004; Shanske et al., 2007). 
The blood-brain barrier is not completely formed in utero, leading to potential 
exposure of the fetal nervous system to maternal Ro/SSA autoantibodies. Askanase and 
colleagues observed an increased frequency of attention-deficit disorder in boys with CHB 
(Askanase et al., 2010). It has also been reported that there might be a higher prevalence of 
learning disabilities and attention-deficit disorders in boys of mothers with SLE (Neri et al., 
2004; Ross et al., 2003). Further studies would contribute to better understanding of this 
complex situation and ensure that the children and families that are involved get adequate 
surveillance and support during pregnancy, growth and school years.  
A serious feature of NLE is the cardiac involvement, which includes arrhythmias and 
different stages of atrio ventricular (AV) block (Friedman et al., 2003; Lee, 2009) which is 
described more detailed below.   
 
1.6  CONGENITAL HEART BLOCK (CHB)  
Heart block that develops during fetal life, CHB, is most commonly associated with 
either congenital malformations or the presence of Ro52, Ro60/La autoantibodies in the mother. 
Sometimes the heart block may occur after viral infections, drug treatment or can be diagnosed 
without any identifiable cause. Heart block may also develop during infancy or early childhood. 
To distinguish true CHB cases from heart blocks developed later in life a new definition of 
CHB has been proposed; heart block is considered as congenital if it is diagnosed during 
pregnancy, in utero, or within the neonatal period (0-27 days of life) (Brucato et al., 2003). 
These heart blocks are potentially fatal conditions with conduction abnormalities in a 
structurally normal heart (Buyon and Clancy, 2003). 
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The congenital heart block observed in NLE usually develops during gestational 
week (GW) 18-24. The maternal Ro/SSA and La/SSB autoantibodies are transported from the 
mother to the fetus across the placenta during pregnancy. Maternal anti-Ro52 antibodies are 
directly connected to the development of CHB, although the molecular mechanisms are still to 
be unraveled (Salomonsson et al., 2002). Further, since the recurrence rate is only 12-17%     
(Ambrosi and Wahren-Herlenius, 2012; Buyon et al., 1998; Julkunen and Eronen, 2001; 
Solomon et al., 2003) despite persisting maternal autoantibodies, other factors besides 
antibodies are needed for the full establishment of CHB. 
 
1.6.1 Atrio ventricular block I, II and III 
CHB is defined as a block or a delay in the signal conduction at the AV node and can 
be divided in three degrees of severity. The process may be initiated as a first degree block and 
can progress through second degree and eventually to a complete third degree block (Bergman 
et al., 2009; Clancy and Buyon, 2004; Litsey et al., 1985). In first-degree AVB (AVB I), the 
electrical impulses are slowed down as they pass through the AV node. AVB I is characterized 
by a prolonged interval between atrial and ventricular contractions (AV interval) but with 
normal and atrial and ventricular rates (Jaeggi and Nii, 2005). 
In second degree AV block (AVB II), some, but not all, impulses reach the 
ventricles. AV block II exists as three different types. Mobitz type I, with a progressive 
prolongation of the AV conduction, Mobitz type II with block of an isolated impulse without 
lengthening of the AV conduction time, and 2:1 second degree AV-block which is characterized 
by blocking every second atrial impulse. A third degree, complete heart block, (AVB III) occurs 
when no signals are conducted through the AV node. This results in a low ventricular rate, 
bradycardia, usually between 50-70 beats per minute (bpm) while the atrial rates are usually 
normal, (110-150 bpm). AVB I and AVB II are both considered as reversible but AVB III in 
CHB is considered to be permanent and usually results in need for a pacemaker after birth 
(Eronen et al., 2000; Sonesson et al., 2004; Waltuck and Buyon, 1994). Lately, a publication of 
reverting AVB III has however challenged the permanency of the third-degree block (Trucco et 
al., 2011).                                                                                            
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Figure 3. The electrical impulses in a normal heart and a heart with heart block. 
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A)                            B) 
 
Figure 4. 
(A) ECG showing normal sinus rhythm, first, second and third-degree AV-block. 
(B) A schematic picture of a normal ECG curve. The PR interval is measured from the start of 
the p-wave (depolarization of the atria) to the beginning of the QRS complex (depolarization of 
the ventricles).  
 
1.7 CLINICAL ASPECTS OF CONGENITAL HEART BLOCK 
1.7.1 Incidence 
 CHB is a rare disease with an incidence in newborn children of 1/15.000-20.000 in 
the general population (Michaelsson and Engle, 1972). The prevalence of having a child with a 
third- degree block is about 1-2% in women positive for Ro/SSA autoantibodies (Brucato et al., 
2001; Buyon et al., 2001; Friedman et al., 2002). If the maternal anti-Ro activity is targeted to 
the 52-kd component of the Ro antigen, it has been suggested to be even more frequent (Buyon 
et al., 1993; Julkunen et al., 1998; Salomonsson et al., 2002). In cases where the mother 
previously gave birth to a child with CHB the recurrence rate is 12-17% (Buyon et al., 1998; 
Julkunen and Eronen, 2001; Llanos et al., 2009; Solomon et al., 2003). If the mother previously 
had a child with NLE involving the skin the occurrence of cardiac involvement has been 
reported to be 13% in the next child (Izmirly et al., 2011). The incidence for AVB I in Ro/SSA 
positive pregnancies range from 9 % to 33% depending on cut-off values employed for defining 
the AVB I (Bergman et al., 2009; Friedman et al., 2008; Rein et al., 2009; Sonesson et al., 
2004). 
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The first sign of a mother being Ro/SSA autoantibody positive can be that the fetus 
shows signs of heart block. As these mothers are not aware of their autoantibodies, offering 
fetal surveillance during pregnancy will not be possible unless a general screen of Ro/SSA 
autoantibodies in early pregnancy is introduced. It also indicates that the fetus is very sensitive 
to the maternal biosystem. 
 
1.7.2 Morbidity and mortality 
CHB has a mortality of 15-30% (Buyon et al., 1998; Jaeggi et al., 2002; Schmidt et 
al., 1991; Waltuck and Buyon, 1994). The outcome for patients with congenital heart block 
depends on the presence or absence of underlying structural heart disease, as well as the rate of 
ventricular activation and the presence or absence of congestive heart failure (Friedman et al., 
2003). If the heart rate is lower than 55 beats per minute (bpm) during the fetal period there is a 
high risk of fetal loss (Jaeggi et al., 2002). The presence of fetal hydrops or other signs of 
physiologic disturbance in cardiac function are also poor prognostic signs (Friedman et al., 
2003). If the congenital heart block is diagnosed in the newborn period (0-27 days of life), and 
structurally normal, the condition is associated with a very good prognosis for long-term 
survival (Buyon et al., 1998; Eliasson et al., 2011). The majority of the surviving children need 
a pacemaker in early life (Buyon et al., 1998; Eronen et al., 2000; Waltuck and Buyon, 1994). 
 
1.7.3 Surveillance and treatment of CHB during pregnancy 
Fetal echocardiograpic and Doppler methods are the dominating modality for 
prenatal diagnosis of fetal cardiac rhythm, conduction, and function. Advances in signal 
processing have improved the acquisition of transabdominal fetal electrocardiography (ECG), 
but atrial depolarization’s (p waves) are still difficult to detect. Another technique to follow the 
development of the fetal heart is magnetocardigraphy. This technique provides a better quality 
of the signal than ECG, but it is expensive and requires a magnetically shielded room. The 
technique is available in a few centers, but not in Sweden. Assuming that CHB is a gradually 
progressing and preventable disease, starting during a critical period in mid gestation, methods 
to detect first degree heart block have been developed. By monitoring the development of the 
fetal heart during GW 18-24 a correct diagnosis can be made (Andelfinger et al., 2001; 
Bergman et al., 2006; Sonesson, 2010).  
Ultrasound Doppler methods have been developed with reference values established 
to detect first-degree atrioventricular block (AVB) (Andelfinger et al., 2001; Glickstein et al., 
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2000). It has been shown that signs of first degree heart block occur in up to 1/3 of fetuses of 
autoantibody positive women (Sonesson et al., 2004). These blocks revert spontaneously in the 
majority of the fetuses, but progression to a more severe block may occur in some. In these 
cases the surveillance may enable early treatment of the pathogenic process, and maybe reverse 
the inflammatory process in the fetal heart (Sonesson et al., 2004; Theander et al., 2001). 
Different ways to improve the outcome in fetuses with CHB, including anti-inflammatory 
treatment with steroids, (Bierman et al., 1988; Buyon et al., 1987; Saleeb et al., 1999) 
intravenous immune-globulins (IVIG) (Kaaja et al., 1993; Kaaja et al., 1991) and 
plasmapheresis (Makino et al., 2007; van der Leij et al., 1994) have been used.   
Fluorinated steroids (betamethasone and dexametasone) are the most commonly used 
treatment. Steroids are used to reduce the inflammatory process in the fetal heart to avoid or 
decrease the injury in the fetal heart. Fluorinated steroids cross the placenta without being 
metabolized (Blanford and Murphy, 1977). Even if CHB is established, treatment with steroids 
might decrease the inflammation in the fetal heart and increase the fetal cardiac output. As a 
complement beta-sympathomimetics may be used (Hutter et al., 2010). Fluorinated steroids 
administered to non-complete AV block have been indicated to prevent progression or even 
revert the block (Buyon et al., 1995; Friedman et al., 2008; Rein et al., 2009; Rosenthal et al., 
1998; Saleeb et al., 1999; Theander et al., 2001).  However, the use of fluorinated steroids is 
connected with adverse effects for both mother and child. Main risks for the mother includes 
infection, hypertension, glucose intolerance, osteoporosis and preeclampsia. The main risk for 
the fetus includes oligohydramnios, growth restriction and risk for negative neurological 
development (Hutter et al., 2010) As mentioned above, other therapies can be used, although 
evidence based results of its efficacy is lacking  The use of injection of immunoglobulin, IVIG 
was first assumed to block the maternal autoantibody transport to the fetus (Hutter et al., 2010), 
but other studies showed no benefit of the treatment in preventing complete AVB (Friedman et 
al., 2010; Pisoni et al., 2010). Using plasmapheresis treatment is a way intended to reduce 
maternal Ro/La autoantibodies in the maternal and thereby fetal circulation and in that way 
protect the fetal heart from damage, but the studies performed all combined the treatment with 
transplancental steroid treatment and its efficacy is therefore difficult to assess (Barclay et al., 
1987; Buyon et al., 1987; Ruffatti et al., 2012; Saleeb et al., 1999). Since no studies at the 
moment are adequately powered to answer the question as to which management strategy of 
Ro/SSA positive pregnancies will result in the best prenatal and long time outcome (Cuneo et 
al., 2010), and there is no consensus among experts in how to best meet the challenge in this 
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complex situation, it is extremely important for the team that work with the family to adjust to 
each individual condition.  
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2 AIMS OF THE STUDY: 
Congenital heart block may develop in the fetus of women with Ro/SSA 
autoantibodies. The potentially lethal autoantibody-mediated congenital heart block is rare, and 
studies investigating the experience of pregnancy in Ro/SSA autoantibody positive women are 
lacking. The overall aim of this thesis was to explore and understand Ro/SSA autoantibody 
positive women’s experiences of pregnancy and the time thereafter, with the goal to identify 
potential areas for improvement in care and routines.  
 
The thesis was structured into six studies of different character: 
 
• Two initial interview-based qualitative studies aimed at acquiring an in-depth 
understanding of Ro/SSA autoantibody positive women's experience of pregnancy, and to 
generate hypotheses to be tested in larger groups of individuals (paper I and II). 
 
• Three following studies aimed at testing the interviewed-derived hypotheses on 
information, emotional reactions, support, organization of care around Ro/SSA positive 
pregnancies and elements related to the postnatal period derived from the first interview 
studies (paper I, II) in larger groups of individuals using questionnaires (paper III, IV, V). 
 
• An additional aim of the thesis was to investigate whether neurodevelopment in children 
born with CHB and their siblings differs from that of the general population, and if so, to 
define factors that might predict neurodevelopment aberrances (paper VI). 
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3 PATIENTS AND METHODS - CONSIDERATIONS 
For a detailed description of patients and methods in this thesis, please see the 
methodological section in each of the included papers. In the following section methodological 
considerations will be discussed, including advantages and disadvantages of the chosen 
approaches.  
In order to fulfill the overall aim for the thesis, data were acquired through both 
qualitative and quantitative research methods. The studies are summarized in Table 1, outlining 
the study design for each paper. The qualitative studies (paper I and II) are based on individual 
semi-structured interviews with one group of women who were at risk for having a child with 
CHB (Doppler group) and one group of women who did give birth to a child with CHB (CHB 
group). The quantitative studies in paper III-V and to some extent paper VI are based on a 
questionnaire which was constructed based on the results from paper I and II. Paper VI is 
mainly based on data extracted from medical records of the children born with CHB and their 
siblings. All women who participated in the studies were positive for Ro/SSA autoantibodies.  
 
3.1 PARTICIPANTS 
One challenge in studying CHB and situations related to CHB is that CHB is rare. In 
paper I and III we invited Ro/SSA positive women who had participated in the surveillance 
programme for detecting early signs of CHB at Astrid Lindgrens Hospital (Stockholm, Sweden) 
during gestational week (GW) 18-24 (Doppler group). The establishment of a population based 
cohort of Swedish congenital heart block ( CHB) patients and their families (Salomonsson et 
al., 2011) has facilitated the study by identifying all known cases of CHB in Sweden, but the 
numbers of participants are still few compared to studies of many other diseases. In paper III 
and IV we invited identified mothers who had given birth to a child with CHB (CHB group). In 
paper V women from both groups participated (paper V, Table 1). The high percentage of 
participating mothers of index cases is strength, but there are also limitations. First, participants 
in paper IV and V are born within a long period of time, between 1929 and 1978. During this 
time a lot of routines have changed in the Swedish health care system and the knowledge about 
CHB and how to manage patients at risk has increased. Also the standard of keeping medical 
records during this time have changed and developed substantially.  In paper VI individuals 
born 1974-2009 were included. Rules and regulations regarding keeping medical records within 
the primary health care and school health care have also developed over the years. 
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All the women in paper I and III participated in the same surveillance programme 
met the same nurses and doctors involved in the programme, and had the same information on 
the risk and diagnosis. The advantage is obviously the continuity but the disadvantage could be 
that if information or knowledge was missing, this could influence all participants. Another 
consideration is that the studies of the thesis were addressed only to the women/mothers. In a 
complicated situation when a fetus/child is at risk the partner and the whole family usually is 
involved and this has not fully been reflected or has been taken in consideration in this thesis. 
However, it should be pointed out that this is the first investigation where the experiences from 
Ro/SSA autoantibody positive women are studied and this work could be used as a starting 
point for future studies. 
 
3.1.1 Doppler group 
The women in the so called "Doppler group" are all Ro/SSA autoantibody positive. 
They were referred to the pediatric cardiology clinic at Astrid Lindgrens hospital at the 
Karolinska University Hospital between 1998 and 2010 to follow the development of the fetal 
heart during GW 18-24. None of the women in this group gave birth to a child with CHB. When 
the work with paper III started 100 mothers had undergone the surveillance programme and 
79% agreed to participate (n=79) in paper III and V. A subgroup of these women were 
interviewed in paper I (n=14). 
 
3.1.2 CHB group 
Participants in the so called "CHB group" are all women who are Ro/SSA 
autoantibody positive and who gave birth to a child with CHB. They were identified through the 
population-based cohort of Swedish CHB patients described earlier by Salomonsson and 
colleagues (Salomonsson et al., 2011). When the work with paper IV started, 88 living mothers 
had been identified, and 89% agreed to participate (n=78) in paper IV and V. The children born 
with CHB were diagnosed at different time points. Depending on when the mother got the 
information on the child’s diagnosis her experiences differed. In paper IV we therefore divided 
the mothers into two groups; diagnosis set in utero - In utero group, diagnosis set day 0-27 and 
later –Post partum group (paper IV, Figure 3A). 
A subgroup of the women in the In utero group were interviewed in paper II (n=21). 
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3.1.3 Neurodevelopmental follow-up 
In paper VI, data were extracted from medical records from children primary 
healthcare centers and school health services to retrieve data on impairment in the following 
categories of neurodevelopment; motor skill development, speech, attention, learning and 
behavior. Data on neuropsychiatric diagnoses were also retrieved.  The children were identified 
through the populations based cohort of Swedish CHB patients described above. Medical 
records were collected from children with CHB (n=60) and their siblings without CHB (n=54) 
born 1974-2009 (n=114). An advantage of this study is the availability of the records, while a 
disadvantage is its retrospective character. A prospective study is however difficult to perform 
considering the rarity of the condition. 
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Table 1. Methods and studied participants of included papers. 
 
Paper Study area Number of 
participants 
Study group Data collection 
method 
Data analysis method 
I Women’s description of being 
pregnant when SSA/Ro 52 
autoantibody positive 
n=14 Doppler Semi structured 
interviews 
Qualitative content analysis 
III Women´s description of 
expecting a child with CHB 
n=21 CHB Semi structured 
interviews 
Qualitative content analysis 
IIII Ro52 autoantibody-positive risk 
pregnancy and serial Doppler 
examinations 
n=79 Doppler Questionnaire Descriptive statistics 
Fishers exact test 
IV The women´s need when being 
pregnant with a child having 
autoantibody-mediated CHB  
n=78 CHB Questionnaire Descriptive statistics 
Fishers exact test 
V     
 
Ro52 autoantibody positive 
women's experiencies after 
childbirth 
n=157 Doppler, 
CHB 
Questionnaire Descriptive statistics 
Fishers exact test 
Spearman correlation 
VI Neurodevelopment in children 
with and without congenital heart 
block born to anti-Ro/SSA 
positive mothers 
n= 114 CHB-
children, 
siblings 
Medical records The Chi-square test or the two-sided Fisher’s exact test 
Logistic regression analysis 
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3.2 METHODS 
3.2.1 Qualitative research method 
3.2.1.1 Semi structured interviews 
Paper I and II are based on semi-structured interviews. The semi structured 
interviews in this work were performed individually using an interview guide (Paper I). The 
questions were open-ended, with the main focus on letting the women describe feelings and 
situations that they had experienced during their pregnancy and post-partum period. The 
interview guide was produced through discussions within the research team and was tested in 
pilot interviews. To verify the readability, the members in the research group read the questions. 
One pilot interview was thereafter performed in the Doppler group and one in the CHB group, 
and after discussions and input the interview guide was slightly adjusted. Depending on the 
individual interviews, follow up questions were asked when clarification was needed. 
Suggestions and comments from the participants were encouraged in order to supplement 
information retrieved through the interview guide. The duration of the interviews was between 
45-90 minutes. The interviews were performed based on the women’s preferences for time 
point and location. 
The interviewer in a semi-structured interview generally has a framework of themes 
to be explored. However, the specific topic or topics that the interviewer wants to explore 
during the interview are usually thought about well in advance. It is generally beneficial for 
interviewers to have an interview guide prepared. A semi-structured interview is flexible 
allowing new questions to be brought up during the interview depending on information 
contributed by what the interviewer says (Graneheim and Lundman, 2004). Interview guides 
can help researchers to focus the interview on the topics at hand without constraining them to a 
particular format. This freedom can help interviewers to tailor their questions to the people they 
are interviewing and to the context and situation. The disadvantage can be that the interview is 
focused around a special topic and that topics that the interviewed person would like to express 
can be missed. It is also possible that the interview is not as exploratory and in-depth as it would 
be if the interview was performed without an interview guide (Britten, 1995; Halcomb et al., 
2006).  
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3.2.1.2 Verbatim transcription 
All interviews in this thesis were transcribed verbatim. Names were replaced with a 
number during transcription.  As a second step the transcriptions were read through word by 
word by JT while re-listening to the tape. Verbatim transcription of interview is often used in 
data management in analysis of verbal data (Halcomb et al., 2005).    
 
3.2.1.3 Qualitative content analysis 
After verbatim transcription of the interviews, qualitative content analysis was used 
as the method for analyzing the text generated from the interviews in paper I and II. The method 
can be used in an inductive and a deductive manner depending on the purpose of the study. In 
paper I and II an inductive approach (Elo and Kyngäs, 2008; Halcomb et al., 2006) was used 
due to the assumption that there are no previous studies dealing with how women experience 
being pregnant and Ro/SSA autoantibody positive. Qualitative research is by nature an 
interpretive process and therefore it is important that the researcher is unprejudiced (Byrne, 
2001). The purpose with qualitative research is to understand and describe a specific situation 
(Byrne, 2001). Content analysis is a method that can be used with qualitative data (Elo and 
Kyngäs, 2008). With qualitative content analysis it is possible to systematically analyze text 
material such as semi structured interviews (Graneheim and Lundman, 2004). There are no 
simple guidelines and the results from the analysis depend on the investigator´s skills and 
experiences. For the validity of the results the pre knowledge of the interviewer must be clearly 
stated and taken into consideration in the analysis process (Elo and Kyngäs, 2008).  
 
3.2.2 Quantitative research methods  
3.2.2.1  Questionnaire 
Paper III, IV, V, and to some extent paper VI, are based on results from a 
questionnaire. The questionnaire was constructed based on results from the individual 
interviews in paper I and II. We developed the questionnaire in two parts. The first part (A) was 
generic for both groups (Doppler and CHB) and contained demographic questions such as  year 
of birth, education, marital status, parity and country of origin and factors that may be related to 
risk for CHB, such as tobacco use and sun exposure. Questions concerning maternal health 
included rheumatic diagnosis, knowledge about autoantibodies, health problems related to the 
rheumatic diagnosis, other disease and treatment or medication if any. The second part (B) was 
tailored for the Doppler group and CHB group respectively, and consisted of questions focusing 
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mainly on feelings, situations and experiences during the pregnancy when expecting the child at 
risk. It was organized in themes regarding information, thoughts on the surveillance period and 
the pregnancy in general including emotional reactions, support, organization of care and 
elements related to the postnatal period. There were controlled case questions, statements to 
which the answer was given in a four-graded scale from totally agree to totally disagree, and 
open-ended questions to which specific comments could be added and space was provided for 
adding optional extra information. Again the research group first tested the readability and then 
the questionnaire was sent to participants in the Doppler group and the CHB group. Two 
questionnaires were tested by participants in the Doppler group and two by participants in the 
CHB group. After input they were slightly adjusted and the final version was distributed.  The 
questionnaire was only available in Swedish.   
 
3.2.2.1.1 Open ended questions 
The questionnaire also contained open ended questions. The freely written answers 
could consist of only one word or a sentence or sometimes the answer could be a longer 
description up to one page. The method of using open questions was applied to capture free 
answers from the respondents, without any predefined alternative answers. 
 
3.2.2.2 Medical records 
Paper VI is mainly based on patient data and information extracted from medical 
records. In Sweden, children are followed systematically by nurses and doctors at local children 
primary healthcare between age 0-6 and school health services between 6-19 years of age.  To 
collect clinical data on children with CHB and their sibling’s medical records from child 
primary healthcare centers and school health care services were collected and used to retrieve 
data on the impairment in the following categories of neurodevelopment: motor skill 
development, speech, attention, learning and behavior. Data on neuropsychiatric diagnosis were 
also retrieved from the records. Supplementary information on maternal diagnosis and treatment 
during pregnancy was also retrieved from maternal medical records.  
 
3.2.2.3 Statistical analysis 
Data from the questionnaires were entered in to a MS Excel sheet. To examine the 
contingency between groups and significant associations the Chi square or Fisher's exact test 
when the expected frequency was <5 was applied. Logistic regression was used for predicting 
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the outcome of a dependent variable. All statistical analysis including frequency distribution 
was performed in Graph Pad Prism 5.01 for Windows.  
 
3.3 TIME SPAN  
A limitation of the studies in the theses is the temporal aspect. The time from a CHB 
pregnancy to participation in an interview or in the questionnaire study was often long and also 
differed substantially between subjects. Further, the time aspect differs between the two studied 
groups in that mothers in the CHB group were born 1924-1978 and experienced their 
pregnancies between 1958-2009, while the mothers of the Doppler group were born 1960-1987, 
and experienced their pregnancies 1999-2011. The interviews in paper I were only 14, and a 
reason for so few mothers accepting the invitation to participate in an interview  could be that a 
long time had passed between the pregnancy and the invitation for the interview.  It is possible 
that some women had left their experiences and thoughts behind them and that it was hard to 
recall the memories of experiences and procedures. However, memories from pregnancy and 
delivery are often described as well remembered by mothers (Simkin, 1991). The questionnaires 
were based on the interviewed mother’s experiences. In this group they all gave birth to their 
children within a ten year period (1999-2009), and maybe the questions were designed in a way 
so that was harder to relate to the questions when there was a long time since the experienced 
pregnancy and childbirth. Extra space was however included in the questionnaire to encourage 
all participants to add extra information or share thoughts and experiences that was not included 
in the questionnaire. 
 
3.4 ETHICAL CONSIDERATION 
The participants in the thesis contributed according to their own free will. They were 
ensured confidentiality and were given written information before inclusion in any of the 
studies. The participants were informed that their contribution to this work was voluntary and if 
they choose to decline participation or withdraw from the study it would not interfere with their 
future care or contact with the hospital. No economic compensation was offered to the 
participants. However, if the interview took place outside the woman’s home she was offered 
tea, coffee or a soft drink during the interview. None of the women who agreed to participate 
later withdraw. The participants in paper I and II pointed out the benefits of being able to talk 
thoroughly with someone about their experiences. For some of the participants this was the first 
time since the delivery. 
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Regarding paper VI the participants or parents of children included (if under 18 years 
of age) had all agreed to that clinical data could be obtained from medical records from hospital, 
child health care centers and school health services with written consent.  
To ensure confidentiality, all names were removed before conducting any data 
analysis. Permission from the local ethics committee at Karolinska Institutet was obtained for 
all studies. 
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4 RESULTS AND DISCUSSION 
The overall aim of this thesis was to explore and understand Ro/SSA autoantibody 
positive women’s experiences of pregnancy and the time thereafter, with the goal to identify 
potential areas for improvement in care and routines. Since not all children to Ro/SSA 
autoantibody positive women develop heart block during pregnancy, but are at risk during GW 
18-24 we invited both women who participated in a surveillance  programme and gave birth to a 
child without heart block as well as women who gave birth to a child with CHB to participate. 
Below follows a description of the structure and workflow during the PhD period, and thereafter 
the results are discussed thematically. 
 
4.1 THESIS STRUCTURE AND WORKFLOW 
4.1.1 Interviews, paper I and II 
To learn more and better understand how women experience pregnancy when being 
Ro/SSA-positive we invited women with this experience to participate in an individual semi-
structured interview. All women who had participated in a surveillance programme during 
pregnancy, GW 18-24, at the Karolinska University Hospital in order to follow the development 
of the fetal heart and detect early signs of heart block were invited (paper I). At the time when 
the work with this thesis started 62 women had followed the programme during 1998-2008 and 
14 women agreed to share their experiences. None of these mothers subsequently withdraw. 
How well these 14 women represent the full spectrum of experiences during pregnancy is 
difficult to assess. However, there was a more than10 year spread in the age  of the participating 
mothers, who also represented several different groups of rheumatic diagnoses  and lived in 
many different parts of the country, arguing that the sample was still sized enough to uncover 
the spectrum of experiences during pregnancy in SSA/Ro52 positive pregnancy. It is possible 
that the participating mothers may represent a subgroup of individuals with more concerns than 
those who did not choose to participate, and it is therefore likely that this study does not 
underestimate the negative side of undergoing serial ultrasound/Doppler examinations with the 
purpose to detect deviating AV-time. 
After verbatim transcription of the interviews we analyzed the text with qualitative 
content analysis as described above in section 3.2.1.4. The overall theme “Experience of a high 
risk pregnancy” emerged from the text with the categories information, emotional response and 
support, as shown below (Figure 5). 
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Figure 5. Description of theme categories and codes from paper I. 
  
 
As a second step we invited all mothers who had been pregnant with a child with 
CHB during 2000-2009 (n=21), to an individual semi-structured interview (paper II). In three 
cases the child died in utero or shortly after birth. The 21 identified women of different ages and 
living in different parts of the country all agreed to participate, and interview results can thus be 
expected to represent the full spectrum of experiences during this period. None of the women 
subsequently withdraw. A drawback with the relatively long period for selecting cases is that 
for some of the women up to a decade had passed since the time of the CHB-related pregnancy, 
which might influence their memory of events and related emotions. However, we did not find 
any systematic differences between the responses obtained from such mothers and those from 
mothers with a more recent CHB-related pregnancy, and studies of traumatic memories indicate 
these are well remembered and reported with richness of details (Porter and Birt, 2001).    
Again, qualitative content analysis was used to analyze the text after verbatim 
transcription. The overall theme was “Expecting a child with congenital heart block”.  Three 
categories emerged from the responses: learning, suspense and facing (Figure 6).  
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Figure 6. Description of theme, categories and codes from paper II. 
 
4.1.2 Questionnaires, paper III, IV, V and VI 
The questionnaires constructed in this thesis were based on the individual interviews 
described above. The questionnaires were used to prove or disprove the hypotheses formed 
from the results from the interviews and to retrieve answers to standardized questions from all 
Ro/SSA autoantibody positive women either participating in a surveillance programme or 
giving birth to a child with CHB identified in Sweden. The mothers were highly motivated to 
participate in the study and the response rate was 79% (79/100) in Doppler-group and 89% 
(78/88) in the CHB-group. When the response rate is above 70%, most resultant biases seem to 
disappear (Lydeard, 1991). Almost all women also choosed to contribute with own comments 
or additional information that they wanted to share. Despite that the period of time since the 
pregnancy differed between the mothers, the answers were detailed and substantial. Even 
though the questionnaire itself was based on questions that emerged from the results of the 
interviews we might have neglected important aspects of the complex situation (Charlton, 
2000). Since the questionnaire was only available in Swedish it is possible that women who had 
another native language did not feel confident in putting their thoughts into written text. It is 
also possible that some women did not understand the questions and therefore choosed not to 
participate. The advantages of using a questionnaire are that data can be obtained in a structured 
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and systematic way and can be addressed to a large number of participants. This data collection 
method is relatively quick and not so costly (Charlton, 2000). Depending on the participant’s 
experiences, interpretation of what a question mean may differ (Bork and Francis, 1985) and the 
method does not give the possibility for follow-up questions, like in the interview studies.   
  
Table 2 summaries initial study aims, interview-derived hypotheses, questionnaire results and 
their implications.     
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Table 2. Summary of main questions investigated during the thesis. 
Study question 
Explored 
Interview-derived hypothesis Questionnaire-deduced impact 
on hypothesis 
Conclusion Comment 
Do Ro/SSA positive women 
know about the risk for CHB? 
Ro/SSA positive women 
experience that they are not 
informed about the risk for CHB 
until they are pregnant, but 
prefer to know before pregnancy. 
Ro/SSA positive women often 
experience that they are not 
informed about the risk for CHB 
until they are pregnant, but the 
majority reported they would 
have prefered to know before 
pregnancy. 
Information on risk for CHB 
should be communicated when 
Ro/SSA positivity is detected. 
Some individuals responded they 
preferred not to have knowledge 
about the risk before pregnancy. 
In total 6% of the Ro/SSA 
positive women stated knowing 
would have influenced the 
decision to become pregnant. 
What do Ro/SSA positive 
women know about CHB? 
Information provided is  
- insufficient 
- not understood 
- not readily available from 
public sources  
The informant is important for 
whether the information is 
understood and experienced as 
sufficient. Information given by 
someone specialized in pediatric 
cardiology is significantly more 
often experienced as sufficient 
and understood. 
Referral to a pediatric cardiology 
specialist can provide the 
mothers with better 
understanding of CHB.Correct 
and updated information on 
CHB needs to be more available 
for both health care personnel 
and patients.  
More anxiety was experienced 
by mothers who felt they were 
not well informed or did not 
understand the information they 
got. 
Not specifically addressed by 
structured interview questions 
 
Mothers may learn about their 
Ro/SSA autoantibodies and their 
own rheumatic diagnosis or risk 
to develop rheumatic disease 
only when CHB is manifest in 
the child. 
The mother may postpone 
dealing with her own 
diagnosis/risk for rheumatic 
disease.  
Questions not designed to 
address hypothesis 
 
Questions not designed to 
address hypothesis 
  A medical follow-up for the 
mother could be planned to 
ensure early treatment of 
developing rheumatic disease. 
Do serial Doppler examinations 
during pregnancy induce undue 
anxiety in Ro/SSA positive 
women? 
Serial Doppler examinations are 
experienced as a benefit and 
much support is given by the 
involved health care personnel. 
The net impact of the serial 
Doppler examinations is 
positive, with support, guidance 
and information as examples of 
experienced benefits. 
There is no reason to refrain 
from serial Doppler 
examinations due to fear of 
inducing undue anxiety in 
Ro/SSA positive women. 
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How do the women experience 
Ro/SSA positive pregnancy and 
CHB emotionally? 
Anxiety and worry for the fetal 
survival presents when the fetus 
has developed CHB.Support is 
given by family, friends and 
health care personnel. 
Professional psychological 
support is not offered. 
Anxiety and worry for the fetal 
survival is common when the 
fetus has developed CHB. 
Support is given by family, 
friends and health care 
personnel. Most women in the 
CHB group however expressed 
need for additional support. 
Professional psychological 
support is seldom offered. 
Offering professional 
psychological support should be 
considered when CHB has 
developed, as substantially fewer 
than would have accepted had 
been offered professional 
psychological support. 
 
How do the Ro/SSA positive 
women experience collaboration 
between the many involved 
clinics during their pregnancy? 
To be supervised by many 
clinics consitutes a logistic 
problem to Ro/SSA positive 
women, and responsibility to 
carry information between 
clinics rests with the patient.  
The interview-based hypothesis 
was not confirmed - when a larger 
group was consulted the majority 
felt collaboration between 
caregivers worked well. 
 Ro/SSA positive women 
reported that the current 
structure of support was 
satisfactory. 
Notably approximately half of 
the women did not know who 
had the medical responsibility 
for themselves or for their child. 
How do Ro/SSA positive women 
experience the postnatal period? 
Mother's of a child with CHB are 
discharged from the hospital 
without sufficient information on 
the child's condition or what to 
do and whom to contact when 
medical complications occur. 
Women giving birth to a child 
with CHB felt their own needs 
for care were not sufficiently 
met. 
 
Mothers of a child with CHB are 
often discharged from the 
hospital without sufficient 
information on the child's 
condition or what to do and 
whom to contact when medical 
complications occur. 
Maternal needs for medical care 
and psychological support 
should be considered and met if 
possible. 
 
Structured follow-up should be 
planned when discharging a 
child with CHB from the 
hospital. Parents should be given 
oral and written information on 
whom to contact in case of 
medical need.  
 
Is there an increased risk for 
impaired neurodevelopment in 
children with CHB? 
  Both CHB and maternal SLE 
increase the risk for 
neurodevelopmental impairment. 
Follow-up of children with CHB, 
especially if the mother has SLE 
should be planned to ensure that 
the child receives support needed 
if neurodevelopment is impaired. 
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4.1.3 Medical records, paper VI 
To initiate this study we used the Swedish population-based cohort of 
individuals born with CHB and their siblings born to anti-Ro/SSA positive mothers 
during 1974-2009. Clinical data was collected for 114 individuals, 60 children with 
CHB and 54 of their siblings without CHB. In addition to medical records information 
about maternal diagnose and treatment during pregnancy were extracted from 
questionnaires, mentioned above.  
 
4.2 INFORMATION 
Information can be given and obtained in many different ways, depending on 
who is giving the information, who is receiving it and the interplay between those 
involved. Each situation when information is provided and attained is in some way 
unique. Below are descriptions of how the women in both the Doppler group and the 
CHB group received the information regarding the risk for CHB to develop in the fetal 
heart, who gave the information  and how the mothers perceived the information. In 
addition, information was given on autoantibody positivity and/or disease in the woman 
herself.  
 
4.2.1 Healthcare interactions 
Women undergoing a high risk pregnancy commonly meet several different 
care givers during pregnancy. In the initial interview studies a nuanced appreciation of 
how the women experienced the situation with several care givers was expressed. Even 
though most women in paper I talked about the experience of good collaboration some 
women gave examples of problems and conflicts connected with meeting different care 
givers and expressed feelings of being responsible for being a communicator and 
coordinator between the different care givers. The women also reported that it was 
difficult to manage all different appointments and maintain presence at work. This 
illustrates the added emotional and practical load on women with a risk pregnancy like 
this. The lack of communication and coordination from the time from diagnosis to birth 
has also been described in a study with parents expecting a child with congenital 
diagnosis (Askelsdottir et al., 2008). In the studies conducted within this thesis, 47% of 
the women in the Doppler-group met at least four care givers (paper III) and 15% of the 
women in the CHB-group met four or more care givers (paper IV). It must be pointed 
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out that all women in the Doppler group knew about their autoantibody positivity 
before pregnancy and therefore their pregnancies were regarded as a risk pregnancy 
from start. In most cases the women in the CHB group did not know about their 
autoantibody positivity before pregnancy and therefore attended the regular antenatal 
care programme until some deviation was observed. The majority of the women in 
these studies considered that the collaboration between the care givers was good 
(99/125). However, only 55% vs. 50% mothers in the Doppler vs. CHB group could 
recall who had the medical responsibility for herself and 45% vs. 48% could recall who 
had the medical responsibility for the child. 
 
4.2.1.1 Timing of information 
When the mother´s own diagnosis of rheumatic disease was unknown, we 
observed that it was most likely that the information about risk for CHB was presented 
to the woman when she was already pregnant (paper II and IV). However, this was also 
true for a substantial part of women with known rheumatic disease and identified 
Ro/SSA autoantibodies (paper III). To not learn about the risk until far into a pregnancy 
was described by some women like “being faced with an accomplished fact”, and that 
they felt powerless. More than half of all women 54% (87/161), stated that they would 
preferred to have the information about the risk for CHB before pregnancy while 18% 
stated they would not have wanted to know and 28% did not know if they wanted to 
know before pregnancy. Whishes for adequate information when having to deal with 
parental decision-making in congenital heart diseases was also observed by Hoehn and 
colleagues (Hoehn et al., 2004).  The answers show that it is important to share 
information available as soon as the autoantibody positivity is known. Information 
before or during initial stages of pregnancy may help the women and families to 
prepare and discuss the potential situation with health care professionals. 
 
4.2.1.2 The informant 
The person that informed the woman about a potential risk for heart block 
differed depending on when the autoantibody positivity was discovered. The content of 
the information on CHB also differed considerably depending on where the mother 
lived and who she met at the care unit as described below.  
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4.2.1.3  Initial informant 
For 50% of the women from paper I and III the first person to inform the 
Ro/SSA positive women about the risk for CHB was the rheumatologist, usually before 
pregnancy in connection to information about the autoantibody positivity when it was 
discovered. Other persons to first give information on the risk CHB to women who 
later participated in the Doppler surveillance programme was an obstetrician (7%), a 
midwife (13%) or in 29% other persons (friends, family and in two cases a university 
teacher). For the women in the CHB-group a midwife at the antenatal clinic was often 
the first to discover that the fetal heartbeat frequency was lower than expected. At this 
stage the mothers usually received information only on that there was something amiss 
with the baby’s heart frequency. This generally, but not always, depending on where 
the mother lived, led to a consultation with medical expertise where some, but often 
inadequate information on CHB was given. Considering the rarity of CHB, the low 
level of this specific knowledge, especially in peripheral units of the health care system 
is hardly surprising, and it can be difficult to accumulate adequate experience in 
unusual diagnosis to impart the information accurately (Crang-Svalenius et al., 2003; 
Larsson et al., 2010) During the last decades technical developments have brought 
many positive effects in diagnosing, resulting in detection and treatment of fetal 
malformations to a larger extent. This puts the health care personnel in a new situation, 
as they are expected to cope with the complexities of diagnosis and decisions, while at 
the same time being sensitive to the feelings of the parents, to be aware of their own 
emotions, and to keep parents informed (Birkeland et al., 2011). 
 
4.2.1.4 Major informant 
For the women who attended a Doppler surveillance programme or women 
in the CHB-group who were referred to a pediatric cardiology center the major 
informant was the pediatric cardiologist. For the group that for different reasons did not 
meet a pediatric cardiologist, the major informant was often a rheumatologist or an 
obstetrician.  
 
4.2.1.5 Information content 
Depending on where the woman lived and who she met in the chain of care 
the content of the information differed a lot.  
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4.2.1.5.1 Information on risk for CHB (paper I and III) 
Almost all women who knew about their autoantibody positivity before 
pregnancy got information that a future pregnancy could involve additional risks and 
rather focused on the need for attending specialist antenatal care during pregnancy than 
on any expected risk for the fetus. However, the information was most often given to 
them when they were already pregnant and the vast majority (99%) of the women in the 
Doppler-group felt they understood the information about the risk of CHB in the 
expected infant. Although the majority had received the information after becoming 
pregnant, notably, most of the women reported that they would have preferred to be 
informed before the pregnancy. 
 
4.2.1.5.2 Information on CHB (paper II and IV) 
Most of the women in the group that gave birth to an infant with CHB got 
the information about CHB when they were already pregnant. They expressed a feeling 
of being faced with an accomplished fact, and described the situation as overwhelming 
and disconcerting. It was clear that the information and procedures differed a lot 
depending on where in Sweden the family lived and whom they met in the health care 
system. Being in a stressed situation gave them less time to adjust to and plan and 
prepare for the situation, and the health care personnel showed a lack of practice when 
trying to manage the situation and to give adequate information. All women wanted as 
much information as possible, even thought it was sometimes hard to take in and 
understand what the situation would involve. This result is in line with other studies on 
how parents knowing that their child will be born with a congenital malformation 
answer (Fioravanti, 2002; Hoehn et al., 2004). Within the CHB-group only 41% of the 
women thought that the information was sufficient and 71% stated that they understood 
the information. The mothers who were informed by a pediatrician specialized in 
cardiology and who had the experience of how to inform about and how to follow up 
the condition after pregnancy, significantly more often thought the information was 
sufficient and comprehendible.  
 
4.2.1.5.3 Information on maternal health - “I will deal with my situation later" 
Almost all of mothers who came to the pediatric center for surveillance of 
the development of the fetal heart, had a rheumatic diagnosis and all were informed that 
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they were positive to Ro/SSA autoantibodies. If they had a rheumatic diagnosis, they 
had had the possibility to discuss their diagnosis with a rheumatologist at some point. 
For the participants in paper II and IV the situation differed considerably. The first sign 
of being at risk for a rheumatic disease in the future was the low heart rate in the fetus. 
The majority (76%) of the mothers in paper II, had no knowledge of their own 
autoantibody positivity. For women who learned about a rheumatic diagnosis or future 
risk for developing a rheumatic disease during their pregnancy, it was noticeable that 
information about their own health and the ability to adapt and manage this new 
situation was secondary. It was not uncommon that they said that they did not have 
time to think about their own condition yet, or that no one had informed them in a 
sufficient way. Some expressed that it was hard to get a perspective and understand the 
prognosis. The most common approach was to concentrate on the infant’s condition 
and to postpone thoughts and reactions on their own condition. For some of the women 
in paper II the interview situation was the first time that they actually talked about and 
actively thought about their own autoantibody positivity and its implications.  
 
4.2.1.5.4 Missing information 
When interviewing the women (paper I, II), they expressed that information 
was missing in different ways. Women attending the Doppler/Ultrasound surveillance 
programme, expressed that the information from the pediatric cardiologist was 
sufficient. It was however hard to find information elsewhere, either to find out more or 
verify the information given to them. Again, for women who got information about that 
their child had CHB during pregnancy the situation was different. They expressed that 
the staff had sparse information to give. The information was not sufficient and the lack 
of experience among health care personnel was obvious in many situations. The results 
from the questionnaires (paper III, IV) showed a slightly different picture compared to 
the interview studies; in the Doppler-group 14% felt that the information on CHB was 
not sufficient and in the CHB-group 59% thought the information was not sufficient.  
The knowledge about the connection between Ro/SSA autoantibodies and 
CHB has grown considerable over the last ten years (Salomonsson et al., 2002) and so 
has also the possibility to detect early signs of heart block (Sonesson et al., 2004). Since 
CHB is a rare condition it is not likely for a caregiver to encounter this situation 
frequently, and the information available is brief. Structured surveillance programmes 
and adequate information is not yet accessible in all parts of the country. Information 
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on rare diseases signify a special problem for which fully updated information cannot 
be expected at all remote units, and the need for policy’s and plans for rare diseases 
have been highlighted lately (Forman et al., 2012). 
 
4.2.1.5.5 Comprehending information 
The language is the key to much of our communication; it gives us words to 
express experiences, feelings and to share information. When analyzing whether the 
women had the knowledge about the connection between autoantibody and the risk for 
the fetus to develop CHB, we found that the Doppler-group reported a high grade of 
understanding this connection (92%). Analyzing the same question for the CHB-group 
the reported understanding of the connection was lower (64%). Notably, the majority in 
the Doppler-group got the information about the connection from a practiced pediatric 
cardiologist at a highly specialized center in a structured manner. The demographic 
parameters of the CHB-group differed considerably and the majority of the women got 
the information from someone that not was specialized, the information was given in a 
peripheral unit, and also the information was given in a more acute way when the first 
signs of heart block were observed.  
  It is shown that families filter prenatal diagnostic information through 
their own personal and cultural frameworks and that this may help them to process it 
into a context that has a meaning for them. However, most families do not have 
previous understanding of genetic or fetal development and are therefore unprepared 
for the scope of medical information they will have to process, and can have difficulties 
in believing what they are told (Allen and Mulhauser, 1995; Maijala et al., 2002). When 
we asked the women in both groups, whether the information about the risk for heart 
block would have influenced their decision on having a child or not, 79% in the 
Doppler group and 57% in the CHB group denied. However, it must be emphasized 
that the question is asked retrospectively and it is in a way a hypothetical standpoint. 
 In both the Doppler group and the CHB group the educational level was 
high. The majority had two or more than two years of university education, 72% and 
53% respectively. This indicates that the women were used to grasp information and 
are probably used to find and acquire adequate information by themselves. 
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4.2.2 Self-sought information 
All women in these studies tried to seek for information on their own in 
some way, even if they thought that the information given to them was accurate and 
understandable. This is also described by others and the need of additional information 
after receiving information about suspected malformation or risks is great according to 
a study by Maijala and colleagues 2002 (Maijala et al., 2002). Also, parents often seek 
information independently about their unborn child’s condition from available literature 
and internet (Askelsdottir et al., 2008).  
 
4.2.2.1 Alternative sources 
Different sources to seek information were used by almost all women as 
reported in both interview and questionnaire studies (papers I-V). During the last two 
decades Internet has grown to be a main source of information for the general public 
(Chauhan et al., 2012), also regarding health issues and it was used by many mothers in 
our study (data not shown). Other sources were books, and also to seek information 
from family, friends and teachers.  
 
4.2.2.2  Content and quality 
Even thought the women did find alternative sources to get information, the 
content and quality differed a lot and was not updated. Information both in the literature 
and from the Internet was inadequate and diminutive in many cases. Accurate 
information was very hard to find for some of the women (paper I). In addition, the 
condition is very rare, and the knowledge about the connection between Ro/SSA 
autoantibodies and risks for the fetus during pregnancy as well as surveillance and 
treatment options is scarce. 
 
4.2.3 Information - Summary 
The information available on heart block is limited both for health care 
personnel as well as in the society as a whole. It can be assumed that it is unlikely that 
involved personnel in the chain of care surrounding a pregnant woman will come 
across this condition often enough to manage the situation without close collaboration 
with colleagues. We found that the information on heart block given differed a lot 
depending on where the woman lived and who she met in the chain of care. This thesis 
shows that there is a large difference in how the women understand the information 
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depending on if it is communicated to her from a pediatric cardiologist with the 
experience of the condition and handling of the situation, compared to someone not 
specialized in pediatric cardiology. In a study focusing on parents´ need of information 
when their child were at risk to be born pre-term 78% agreed that the consultation 
relieved some of their worry and anxiety about their child when being informed by an 
antenatal specialist (Yee and Sauve, 2007). Our data show that the majority of the 
involved women wanted the information about risks connected to their autoantibody 
positivity as soon as it was detected, if possible before pregnancy, to be able to adjust to 
and prepare for the situation. The women who got information about their autoantibody 
positivity at the same time as their child was diagnosed with CHB did not get the 
opportunity to discuss their situation in a more controlled setting. When trying to find 
information on their own, the women had difficulties to find information that was 
reliable and updated.  
Increased awareness and knowledge of CHB is needed, and adequate 
information about the risk of CHB should be given to the woman as soon as Ro/SSA 
autoantibodies are detected. To get updated and adequate information the women 
should be given information from someone who is experienced in the field and the 
information should preferably be given both verbally and in written form (Asplin et al., 
2012). Ideally, information online should also be provided, to be easily accessible both 
for involved health care personnel and for the families. To be connected with or 
referred to a specialized center during pregnancy benefits the women. 
 
4.3 EMOTIONAL RESPONSE IN RO/SSA POSITIVE PREGNANCIES  
Information on CHB led to some kind of emotional reaction for all women in 
this study, and their reactions among other things depended on when, were and how 
and from whom the information came. Often the information led to a feeling of being 
in a stressful situation and the women expressed a feeling of being subjected to an 
unyielding fact, and described the situation as overwhelming and disconcerting.  
 
4.3.1 Feeling safe or not, in an uncertain situation 
Results from the studies included in this thesis show that the feeling of being 
secure was mainly based upon whom the women met in the chain of care and the 
quality of the information given to them. For the women in the Doppler group the 
uncertain situation occurred during GW 18-24 when there is a risk for the fetus to 
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develop CHB. All these women were referred to a pediatric cardiologist center for the 
purpose to detect early signs of AV-block by using Doppler/Ultrasound technique. The 
overall responses from these women were that they felt safe with the supervision and 
the interaction with the staff at the specialized clinic. They felt welcomed to the 
cardiology center, well cared for and well informed by the staff involved. In the 
Doppler group, 61% of the women stated that the extra examinations influenced their 
pregnancy, but almost all commented that the influence was positive and that the 
situation had advantages. The women made clear that the Doppler examinations in a 
way were a positive factor giving them a stronger connection and a possibility to 
interact with their unborn infant. In some cases they also felt it was an improvement in 
the relationship with their partner during this uncertain situation. This was also found in 
a study by Kovalchin and colleague when looking at impact of fetal echocardiography 
(Kovalchin and Silverman, 2004). Some women also described that it was a relief that 
someone shared the responsibility and guided them through the risk period (paper I). It 
is notable that 66% of all women responding to the questionnaire (paper III) felt calm 
before the Doppler examinations despite the complex situation. This highlights the need 
for specialized care with experienced personnel with practice of communicating and 
managing complex and traumatic situations (Birkeland et al., 2011; Zecca et al., 2006). 
For women in the CHB group, the situation was very different compared to 
the Doppler group. They got the information without being prepared, often during a 
regular examination at the antenatal clinic. The lack of experience among the involved 
personnel appeared to strengthen a feeling of being insecure (paper II and IV).  When a 
fetal abnormality is detected, information on prognosis is often variable and uncertain 
(Howard, 2006). The women in the CHB group in most cases also had to handle two 
diagnoses at the same time. The majority (76%) of the women in paper II were without 
symptoms of a rheumatic disease when the heart block was detected in the fetus, and in 
most cases did not know about their autoantibody positivity. These findings correlate to 
similar previous findings that Ro/SSA-positive mothers are often without signs of 
rheumatic disease and the Ro/SSA positivity unknown at the time of CHB development 
in the fetus (Julkunen and Eronen, 2001; Press et al., 1996). As described earlier, the 
woman’s own potential diagnose or risk for development of rheumatic disease was not 
always discussed, and it was very common for the woman to postpone the insight of 
what it could mean. 
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4.3.2 Feelings of concern and anxiety 
High levels of anxiety and psychological distress have been documented in 
pregnant women when a fetal malformation is suspected, diagnosed (Petersen and Jahn, 
2008) or when the diagnosis appears ambiguous (Kaasen et al., 2010). The women in 
the CHB group were significantly more stressed and felt more anxiety when thinking 
about their child than the women in the Doppler group (p=0.0003). The difference is 
probably based on the fact that the women in the CHB group actually got the 
information about their child’s heart block and the consequences connected with the 
grave and potentially lethal condition whereas the women in the Doppler group during 
GW 18-24 got the information that their child, for the time being, not had developed 
CHB. For one third of the women in the Doppler group the period between GW 18-24, 
just before visiting the pediatric cardiologist for the purpose of detecting a potential 
fetal heart abnormality, was the time when they were most anxious. In the CHB group 
about three-fourths of the women dread what could happen to their child during 
pregnancy. The feeling has been described as “knowing but not knowing” (Askelsdottir 
et al., 2008; Sandelowski and Jones, 1996) with extra stress and tension throughout the 
pregnancy. In general, women undergoing a high-risk pregnancy will experience more 
negative emotions related to their pregnancy than women with uncomplicated 
pregnancies (Gupton et al., 2001). Many women with high-risk factors for fetal 
malformation show high levels of anxiety immediately before the ultrasound scanning, 
but after the examination the levels decrease and continue to decrease longitudinally 
over a period of follow up (Brisch et al., 2003). The main emotional characteristics of 
high-risk pregnant women include anxiety and uncertainty (Clauson, 1996). As 
mentioned above the opportunity to have a consultation with an antenatal specialist 
(Yee and Sauve, 2007) may relieve some worry and anxiety, which we also observed in 
our studies where getting adequate information from a pediatric cardiologist made the 
women significantly more secure when leaving the hospital (p=0.008) and during the 
first weeks at home (p=0.02). 
 
4.3.3 Suspense and “on hold” 
When having the knowledge that the fetus was at risk to develop CHB or 
that the fetus had developed CHB it was common to describe the situation as being kept 
in suspense and putting the pregnancy “on hold”. This has also been reported in a study 
describing what women feel while they are waiting for the results after invasive testing 
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(Carolan and Hodnett, 2009). When the fetus is at risk during pregnancy it has also 
been described as “having one foot in - one foot out”, meaning that the women feel that 
they could not emotionally totally invest in the pregnancy (Cote-Arsenault and 
Marshall, 2000). In a study by O`Brian and colleagues women described the situation  
as “putting the pregnancy in the back of their mind” and trying not to focus on the 
pregnancy, and not prepare anything for their child during pregnancy (O'Brien et al., 
2010). In our study the results showed that it was significantly harder to enjoy 
pregnancy and to plan for things they wanted to do together with the child for the 
women in the CHB group compared to the Doppler group. However, the women 
interviewed in both groups described that it was hard to acknowledge the pregnancy 
and to attach to the unborn infant during pregnancy (paper I, II). A potential effect of 
the management strategy of putting the pregnancy on hold is potentially less time for 
preparing for parenthood. Women who gave birth to an infant with CHB reported 
feelings of uncertainty and hesitation when approaching their infant after it was born 
(paper II, IV). 
 
4.3.4 Feelings of guilt 
Results from paper II and IV show that 48% of the women who expected and 
gave birth to a child with congenital heart block expressed that they felt guilt and that it 
was their fault that the child had developed CHB. When a woman becomes pregnant, 
the mental and psychological preparation for parenthood may start a long time before 
the pregnancy is a fact, but increases during pregnancy (Condon, 1997; Hjelmstedt et 
al., 2006; Leifer, 1977). As described, fantasies about the child and what life will be 
like as a family, as well as increased emotional sense have been suggested to contribute 
to the preparation for parenthood (Stern and Bruschweiler-Stern, 1998). When it is a 
fact that the fetus has an abnormality, parental expectations dash (Larsson et al., 2010), 
and they have to give up the picture they envisioned. Often feelings of guilt is present, 
and also grief, sadness and feelings of having lost the fantasized perfect infant, and the 
fear that one had a role in causing the defect (Brosig et al., 2007; Fioravanti, 2002; 
Howard, 2006). In CHB, the association with maternal autoantibodies is strong, and 
Ro/SSA autoantibodies have been demonstrated to directly induce AV-block in 
experimental models (Ambrosi et al., 2012). However, the recurrence risk being only 
12-17% despite persisting autoantibody levels in the mother indicates that additional 
factors influence fetal outcome in response to autoantibody exposure. Recent studies in 
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both experimental models (Strandberg et al., 2010) and humans (Görgen, 2013) 
indicate that fetal genes are a main factor determining whether CHB develops or not in 
response to Ro/SSA auto autoantibodies. This new knowledge demonstrates that 
genetic fortuitousness of common genetic alleles is a main factor of disease 
pathogenesis and may help in overcoming feelings of guilt. Interestingly, there is also a 
significant paternal increase in transmission of the susceptibility alleles (Görgen, 2013). 
 
4.3.5 Thoughts about determination 
When realizing that congenital heart block had developed in the fetal heart 
an initial feeling of uncertainty and doubtfulness of continuing the pregnancy was 
sometimes present (paper II, IV). It is known that acute grief reactions are similar to the 
experiences following a stillbirth or neonatal death (Broen et al., 2004; Zeanah et al., 
1994). This feeling was however temporary and passed for the vast majority when they 
had had a chance to adjust to the information and situation. For one couple, who had 
experienced losing a child due to CHB before, the decision of ending the pregnancy 
was made when signs of CHB occurred once again (paper II). 
 
4.3.6 Emotional response - Summary 
Getting information that something is wrong with the expected child is 
always overwhelming. It is of great importance to take each individuals situation into 
consideration when delivering bad news. To make the woman feel secure in the 
uncertain situation and provide time to ask questions is important. Thoughts about 
determination, at least as an initial reaction, and feelings of guilt are common, and this 
needs to be handled by professionals interacting with the families involved. Being at 
risk as well as knowing that the fetus had developed CHB made the women in many 
cases putting the pregnancy “on hold”. Trying not to think about being pregnant, not 
planning for a child and not fully acknowledging the pregnancy for some time was 
common. Professional support and knowledge about this among the health care staff in 
the chain of care is important. 
 
4.4 SUPPORT 
4.4.1 Given support 
Support given to the women in this study differed a lot depending on where 
the woman lived and whom she met. The vast majority of participating women had 
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received good support from their own family and friends (paper III and IV). Depending 
on whether the woman was at risk for having a child with CHB or actually got a child 
with CHB (Doppler vs. CHB group) the experience of sufficient support differed a lot. 
In the Doppler group 95% of the women felt that the support was enough, compared 
with the CHB group were only 64% of the women were satisfied with the support 
given to them (p=0.0001).  
 
4.4.1.1 Supporters 
In the Doppler group 65% of the women had four or more people supporting 
them (both non-professionals and professionals) and the corresponding proportion for 
the CHB group was 51%. One of the reasons why the women in the Doppler group 
reported that they had more supporting people around them could be that they 
participated in the surveillance programme. Women in the CHB group reported support 
from parents in law and friends less often than women in the Doppler group (paper V).  
  
4.4.1.2 Support need fulfillment 
The women who participated in the Doppler surveillance programme were 
generally satisfied with the support they had received during pregnancy, both from 
professional care givers and from significant others. The contacts seemed to encompass 
different needs, but both kinds of contacts were described as crucial for their sense of 
wellbeing. The women who had support from their family and friends e.g. a wider 
social network, and knew who to contact in the health care system felt less alone and 
more secure (paper V). The experience of the collaboration between the involved care 
units were perceived as good by 81% of the women. However, it was not always clear 
for the mothers who had the medical responsibility for them or for the child (Table 2 in 
paper III). Women in the CHB group reported a greater need for more support (53%) 
than what they actually got. It must be highlighted that this group in general did not get 
support from a specialized pediatric cardiologist. Also the women in the CHB group 
felt that the collaboration between care units was acceptable but there was an 
uncertainty, as in the Doppler group, about whom had the medical responsibility for the 
women herself (50%) and for the child (57%). In paper II some women reported a 
delay after being referred from the midwife who had observed the initially abnormality 
in the fetal heart beat frequency, to the time of the correct management due to lack of 
experience from the physician. An abnormal finding often comes unexpectedly a may 
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be shocking for the women. It is therefore important to give information about the 
finding to the women without time-lag and in a suitable environment (Larsson et al., 
2010). As mentioned earlier in this thesis, CHB is a very rare and uncommon condition 
and it is not likely to accumulate knowledge at all remote care units. 
 
4.4.2 Desired support 
The overall finding in this study is that women at risk for having a child with 
CHB or women who actually got a child with CHB got the best professional support 
from a specialized pediatric cardiologist. This finding correlates well with a study by 
Montis et al where women reported a very high level of satisfaction of the support 
given from the staff at a pediatric cardiology unit (Montis et al., 2010). The positive 
effects of fetal echocardiography have also been discussed in a study by Björkhem et 
al. where fetal echocardiography was indicated to be very important to families who 
previously had a child with malformations (Björkhem et al., 1997).  In their studies of 
fetal echocardiography and psychological effects Sklansky and colleagues found that a 
vast majority had chosen to undergo fetal echocardiography in subsequent pregnancies 
(Sklansky et al., 2002).  In our studies, women who not had the opportunity to receive 
support from a specialized pediatric cardiologist reported a lack of knowledge among 
medical professionals about how to handle the pregnancy and how to manage the 
situation. In a study by Hunfeld et al. the women were significantly more positive to the 
prenatal consultation when meeting a physician with expertise knowledge in the area, 
especially shortly after hearing the bad news (Hunfeld et al., 1999).  
 
4.4.2.1 Additional professional support 
Decades of research demonstrates that women´s psychosocial health strongly 
influences the child (Rosenberg et al., 2010). Paper I, II of this thesis and other research 
projects demonstrate an increased anxiety in women in connection to fetal 
echocardiography (Rosenberg et al., 2010; Sklansky et al., 2002). However, women 
report that the advantages of having fetal echocardiography overweight the 
disadvantages (Sklansky et al., 2002). It is of importance to pay attention to the 
women´s psychological well being during the period of undergoing Doppler/ultrasound 
examination during GW 18-24 to detect early signs of CHB, and to offer counseling 
throughout the pregnancy. In the CHB group only 21% of the women were offered 
psychological support, even though 38% of the mothers had accepted psychological 
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support and 44% did not know. Based on the results from paper I and the results from 
the questionnaire-study, paper IV, and from a study by Brosig et al., it should be 
considered to offer women extra professional support when a fetal malfunction has 
been detected (Brosig et al., 2007). 
 
4.4.3 Support - Summary 
Women undergoing risk pregnancies such as Ro/SSA-related pregnancies 
need support from family and friends. When the condition is rare like CHB, adequate 
care and support from medical staff with experience of managing complex situations is 
important. Offering consistent support throughout the pregnancy and ensure 
collaboration between the involved care units will influence the pregnancy in a positive 
way. Despite the stress and tension connected with Doppler/ultrasound examinations, it 
was a clear benefit for all women to attend the surveillance programme and they 
reported that the interaction with the staff at the pediatric cardiology clinic made them 
feel secure. However offering extra psychological support should be considered 
important especially for those whose child is diagnosed with CHB. 
 
4.5 ORGANIZATION OF CARE AROUND RO/SSA POSITIVE 
PREGNANCIES 
4.5.1 Primary care and specialized centers 
In sparsely populated districts the hospitals generally do not have specialists 
in all medical fields. This can lead to that a physician’s practicing in such a setting lack  
practice and knowledge about the needs for Ro/SSA positive women and their fetus 
during pregnancy which can cause a delay in treatment, surveillance and support. 
Hospitals in the major cities provide closer access to tertiary referral clinics and 
specialists. Information on rare diseases, like CHB, signifies a special problem for 
which fully updated information cannot be expected at all primary care units, and the 
need for policy’s and plans for rare diseases have been highlighted as previously 
mentioned  (Forman et al., 2012). 
 
4.5.2 Involved clinics and their coordination 
When a woman is pregnant and in a high risk situation it is important that 
care givers collaborate and coordinate their care. Women who participated in the 
studies in this thesis reported that they had contact with several care givers in various 
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clinics such as maternity clinic, specialist maternity clinic, rheumatology clinic, 
pediatric cardiology and others. To be in a care situation whit several stakeholders 
involved may induce a complex multifaceted situation for the mother to-be. In paper I,  
women stated that they felt like they had to have the overall view over the pregnancy 
and act like a messenger between the different care-units they attended. However, as 
mentioned earlier, women from both groups in general reported satisfaction with the 
collaboration between the different care givers. Although the opinion of good 
collaboration dominated, only about half of the women could point out who had the 
medical responsibility for herself or for the fetus. This highlights the importance of 
clear communication and coordination about who is medically responsible for the 
women and their fetus. 
 
4.5.3 Doppler examinations 
When being Ro/SSA positive the risk for the fetus to develop CHB occurs 
between GW 18-24.  To detect early signs of heart block and if possible treat the 
condition, women in paper I and III were referred from either their rheumatologist or 
the antenatal care to a Doppler/ultrasound surveillance programme at a pediatric 
cardiology clinic. The examinations were carried out during GW 18-24, usually once a 
week, but the time span between the examinations and the choice of action depended 
on the results from each examination. 
 
4.5.4 Organization - Summary 
Results from this work show that different professionals including 
specialists, family doctors and midwifes can work together to complement each other 
and provide consistent information. However, referral to a pediatric cardiology clinic 
for examinations and consultation is important since CHB is a rare condition and 
mothers attending such a center reported significantly more often that they had 
understood the information and felt more secure and were less anxious after returning 
back home with their baby. Also, the period of time for possible treatment is limited 
between GW 18-24 and rapid detection and subsequent treatment is facilitated at a 
highly specialized center. 
    
 58 
4.6 LOSING THE CHILD IN UTERO OR IN CONNECTION WITH BIRTH 
As described in section 1.7.2, CHB is a condition with high mortality. 
During the work with this thesis, mothers that lost their child late in pregnancy or in 
connection to birth were among the interviewed (paper II). For two of these mothers, 
the interview situation was the first time that they had the possibility to share their 
experiences and thoughts. The mothers that lost their child all described that they had 
the opportunity to see and hold their baby if they wanted to and they could introduce 
the baby to siblings and family. The mothers also described that they had the chance to 
collect a few memories if that was their wish. However, all women described that the 
lack of experience of CHB from the staff did complicate the situation. Losing a child 
during pregnancy or in connection to birth is an inconceivable and extremely stressful 
type of loss and the dimensions of parental grief are diverse, (Cacciatore et al., 2008; 
Kavanaugh and Moro, 2006). The grief is profound and unique for each individual and 
the loss of a stillborn baby has been described as a complex loss (Geerinck-
Vercammen, 1999; Hutti, 2005). There are assertions that both mothers and fathers 
bond with their unborn baby early in pregnancy (Klass et al., 1996). The stillborn baby 
is a part of the parent’s identity in the form of hopes and fantasies that come with 
parenthood (Geerinck-Vercammen, 1999).  Stillbirth usually occurs within a family 
context, where the mother and father, but also older siblings, and extended family 
members are affected (Avelin et al., 2011; Cacciatore et al., 2008; Estok and Lehman, 
1983). It is important that the staff involved offer opportunities for the parents to see 
and hold their baby (Erlandsson et al., 2013). Some stillborn babies have siblings who 
are waiting for a little sister or brother and in addition to the loss of the expected baby, 
siblings also lose their status as a big brother or a big sister (Avelin et al., 2011). 
Children’s grief and their understanding of death are aligned to their intellectual 
development and involve a gradual process (Black, 2005; Dyregov and Dyregov, 
1999).  During the interviews this was highlighted by some mothers (paper II)  
 
4.7 THE POSTNATAL PERIOD 
4.7.1 At the hospital 
The care after delivery was perceived differently between the Doppler and 
the CHB group. Although both groups were generally satisfied with the care of their 
newborn infant, the women in the CHB-group apprehended the care of them self as 
significantly less satisfying than the women in the Doppler group. It should be taken 
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into consideration that in many cases the women and the infants in the CHB group were 
separated directly after birth due to the infant’s condition. Also, the women in the CHB 
group perceived the collaboration between the involved care units as less satisfying 
than the women in the Doppler group. Again this could be a consequence of the fact 
that the infants in the CHB group had to undergo immediate specialist care, and that the 
wards were rather far apart.    
 
4.7.2 Coming home with a child with or without CHB  
The women in the CHB group felt significantly less secure when coming 
home with their infant than the women in the Doppler group (p=0.0012) (paper V). 
There was also a significant correlation between feeling less secure and lack of 
understanding the information given (p=0.0303). The support given to women in the 
CHB group from family and friends was reported poorer compared to the Doppler 
group. The feeling of being afraid and anxious among the women in the CHB group 
after coming home from the hospital was significantly correlated to the given support 
from family and friends (paper V). 
For families that lost their child there was often a lack of professional 
support to help to handle the grief and feeling of guilt. There was also insufficient 
support for going through the course of events and planning for a future pregnancy if 
that was what the couple wished for (paper II).   
 
4.7.3 Child health care centers 
Most women in both groups (Doppler and CHB) contacted the child health 
care center by themselves after coming home. Also in this part of the chain of care the 
experience and knowledge about CHB and the connection to Ro/SSA autoantibodies 
was in general sparse or missing and it was difficult to get information or support. Most 
women reported that they themselves had to inform the personnel at the care unit about 
the risk during pregnancy and the heart block. 
 
4.7.4 Networking 
In our study only 6% of the women in the CHB group had contact with 
another family with a child with CHB and almost one third had appreciated such a 
contact. Some women expressed that talking with someone that had been in a similar 
situation would have been helpful and others stated that they thought that it would have 
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been beneficial for their child to meet someone with CHB, especially when reaching 
adolescence. Among the women in the CHB-group nearly one third had participated in 
the information meetings organized by Karolinska Institutet regarding CHB. Lately the 
knowledge about the importance of networks and policies for rare diseases has 
increased (Aymé et al., 2008; Forman et al., 2012; Schieppati et al., 2008). By 
networking the capacity increases in patient groups and can empower individuals to act 
proactively in self-care strategies to improve health outcome and quality of life (Aymé 
et al., 2008).  
  
4.7.5 Future perspective for the individual  
When being Ro/SSA autoantibody positive each pregnancy is a risk 
pregnancy during GW 18-24 at a greater or lesser degree. On one hand, the woman 
herself may develop a rheumatic disease with time (Julkunen and Eronen, 2001; Rivera 
et al., 2009), and on the other hand if a child is born with CHB, the risk increases to 12-
17% for the next sibling to be born with CHB. Getting adequate and sufficient 
information on the different aspects is of great importance when planning a future 
pregnancy, starting with information on the woman’s autoantibody positivity as soon as 
it is known. It is also important to point out that the risk for heart block is low and that 
there are methods to supervise and if needed treat the condition.  
 
4.7.6 Postnatal period - Summary  
In both the Doppler and the CHB group the care of the child after delivery 
was in general perceived as satisfactory. However, when a child’s health is at risk 
obviously stress for the mother/family increases. It was common that the infants and the 
mothers were separated for some time after delivery due to the infant’s condition. It 
was also found that the women who gave birth to a child with CHB felt less satisfied 
with the care of themselves. Feelings of being forsaken were described. Throughout 
this work the lack of experience and knowledge about CHB and the connection to 
Ro/SSA autoantibodies among health care staff has been obvious, and we also found 
that the mothers who had a child with CHB felt significantly less secure when coming 
home from the hospital. Contact with another family with a CHB child was infrequent, 
but was desired by one third of the families. The need for adequate and sufficient 
information and support was clear, also when planning a future pregnancy if that was 
what the couple’s whish.  
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4.8 OTHER FAMILY MEMBERS 
This thesis is focused on the Ro/SSA autoantibody positive women and their 
experiences of pregnancy and the postnatal period. However, the family surrounding 
the woman must of course be taken in to consideration, including the partner as well as 
the siblings, if any, and extended family members. Future studies should be addressed 
to understand their situation. Information and support to the partner is of great 
importance to make it possible for him/her to process and understand the situation 
(Cacciatore et al., 2013). Also, we did not design studies aimed at investigating the 
experience of living with CHB, which would be helpful to better understand the 
support required by this rare group of individuals. One part of the thesis work was 
however deduced to a follow-up study of neuropsychiatric development in children 
with CHB and their siblings (below). 
 
4.8.1 FOLLOW UP OF CHILDREN WITH CHB AND THEIR SIBLINGS 
(paper VI) 
As described in the introduction, section 1.5, NLE can include many 
different manifestations and also neurologic such (section 1.5.3). Case reports of 
hydrocephalus, non-specific white-matter changes, calcification of the basal ganglia 
and vasculopathy have been published (Silverman and Jaeggi, 2010). Several studies 
have also been published on higher incidence of learning disabilities in children born to 
mothers with SLE compared to children born to mothers without SLE, especially if the 
child is male (Lahita, 1988; McAllister et al., 1997; Neri et al., 2004). When parents 
report signs of neurodevelopmental deviations in their children, a higher frequency of 
dyslexia and decreased mental and sequential mental processing have been shown 
(Askanase et al., 2010; Behan et al., 1985; Yoshikawa et al., 2010).  
In paper VI we used the Swedish population-based cohort of siblings with 
and with and without CHB, including individuals born 1974-2009 to an anti-Ro/SSA 
positive mother in the study. The results from the study show that impaired 
neurodevelopment was reported in 16% (18/114) of all children during the follow-up 
time of 13.0 (8.2-17.5) years. The reported problems included speech (9%), motor (8%) 
and learning (8%) impairment, attention deficit (5%) and behavioral impairment (4%). 
It was significantly more common with attention deficient and learning deficient among 
children with CHB of mothers with SLE than among their siblings. To compare our 
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data with prevalence of impairment in neurodevelopment in the general population is 
difficult. One reason is the retrospective design of our study and another reason is that 
the described neurodevelopment problems are not strict medical or psychiatric 
diagnoses and therefore descriptions and definitions alter over time. 
Five categories of problems were observed in this study and speech (9%), 
motor skill development (8%) and learning impairment (8%) were the most reported 
problems. In the general population speech impairment is reported to be between 1% to 
15% in different studies (Law et al., 2000; Tomblin et al., 1997; Westerlund, 1994; 
Westerlund and Sundelin, 2000). Studies in clumsiness and motor skill development 
showed a prevalence of just above 6% (Kadesjö and Gillberg, 1998). Review articles 
on learning disabilities show a prevalence of around 5% (Lagae, 2008; Lyon, 1996). 
Contrary to the studies above, our study did not show any clear increased risk for 
impairment in neurodevelopment in children born to anti-Ro/SSA positive mothers 
compared to the general population. In our study, disturbances in motor skill 
development were more common in boys than in girls and also influenced by 
gestational age. Attention deficit were however significantly more common in children 
born to mothers with SLE and in children with CHB. An SLE diagnosis in the mother 
did also affect learning disabilities, and a trend towards learning disabilities being more 
common in children born with CHB was noted.  
 
4.8.2 Follow up - Summary 
With the results from paper VI in mind, information on a possible risk for 
impairment and follow- up of neurodevelopment should be considered for children with 
CHB, especially if the mother is diagnosed with SLE. Increased awareness among 
involved personnel in hospitals, child health care centers and schools as well as parents 
and careful management of these individuals and early diagnosis are ways to help these 
children to overcome their difficulties during childhood and school years and make sure 
that they obtain the support needed. To better understand the potential risk of 
neurodevelopment impairment in children exposed to Ro/SSA autoantibodies 
prospective case-control studies will however be needed. 
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5 CONCLUDING REMARKS 
Congenital heart block may develop in the fetus during pregnancy in 
Ro/SSA positive women. CHB is rare, but a life threatening condition. The risk period 
for CHB to develop in the fetal heart is during GW 18-24. During this time, serial 
Doppler/ultrasound examinations may be used to detect early signs of CHB. If needed, 
treatment to prevent further progression or to even revert incomplete AV blocks, can 
then be given. In this thesis interviews and questionnaires were used to explore 
maternal experiences of Ro/SSA positive pregnancy with the aim to identify potential 
areas for improvement in care and routines. 
A main finding of the studies was the experienced low awareness and 
knowledge of CHB and its association with Ro/SSA autoantibodies in the chain of care 
and in society as a whole. An apparent strong need to increase both availability and 
accuracy of information on Ro/SSA autoantibodies and CHB emerged.   
 Most women got the information on their Ro/SSA autoantibody positivity 
and the risk for development of CHB when they were already pregnant.  However, the 
results imply that women prefer to be informed before entering pregnancy, which will 
help to plan for and adjust to the situation. When informing, it is however important to 
point out that the risk for CHB is low, and that there are possibilities to detect and if 
needed possibilities to treat the condition. 
The serial Doppler/echocardiography examinations did not induce anxiety 
during pregnancy, which has been raised as an issue and criticism against performing 
such investigations in a group where the risk for a serious condition is still low. Instead, 
coming to a highly specialized center, being able to ask questions and get adequate 
information and guidance and interact with the health care personnel with experience 
and knowledge about Ro/SSA autoantibody positivity and the risks connected to that 
was experienced as a benefit by the women. When handling a pregnancy with a risk for 
a rare condition like CHB, highly specialized centers thus appears beneficial both from 
a medical and care related perspective. The knowledge of how to provide information, 
surveillance and if needed treatment and support must be kept updated.  For some 
women extra psychological support appeared needed. Offering a follow-up call or an 
extra appointment after passing the risk period is one way to meet the need of some 
women. When a woman is pregnant with a child with CHB it is important to give 
correct and comprehendible information, and adjust to each individual situation. 
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An unexpected observation relating to health care organization and 
information was that the women giving birth to a child with CHB often were unsure of 
whom to contact in case of medical need after leaving the hospital. Clear information 
on where to turn to, both written and verbal, should be provided to the families and may 
be one way to decrease anxiety as a connection between not know where to turn for 
help and more anxiety in the mothers was observed. To bridge the gap between 
different care givers, information should also be provided to personnel at the child 
health care when a child with CHB is coming home. The mothers who gave birth to a 
child with CHB expressed a wish to get in contact with other persons with the 
experience of having CHB in their family. This could be offered through patient 
organizations or an internet-based forum. 
The increased risk observed for neurodevelopmental impairment in children 
with CHB, especially if the mother has SLE, indicates that children with CHB would 
benefit from follow-up to identify neurodevelopmental impairments so they may get 
the support needed.  
The mothers who received information on their own autoantibody positivity 
and their own rheumatic diagnosis or risk for developing a rheumatic disease at the 
same time as their child was diagnosed with CHB, tended not to deal with their own 
situation. Offering a medical follow up after delivery could benefit these women, and 
ensure support and appropriate medical care. 
In summary, this thesis includes the first set of studies exploring maternal 
experience of Ro/SSA positive pregnancy. During this work, focus has been on 
performing a basic characterization of how the women perceived their situation during 
pregnancy. Future studies may explore the effects of interventions. This thesis could be 
used as a starting point.  
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